Physician profile
Robert E Agee
NPI 1417035270
$3,852.86
in general payments reported to CMS, 2019-2025
16 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,269 · 2020: $130 · 2021: $15.74 · 2022: $29.21 · 2023: $174 · 2024: $53.29 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $3,095.34 | 2019 | |
| Stryker Corporation | $151.68 | 2025 | Asnis |
| Metuchen Pharmaceuticals | $130.44 | 2020 | |
| Dexcom, INC. | $118.08 | 2023 | Dexcom G7 Gss (161) |
| Novo Nordisk INC | $112.17 | 2019 | |
| Bioventus LLC | $41.52 | 2019-2024 | Durolane |
| Kerecis Limited | $37.99 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Averitas Pharma INC. | $29.74 | 2025 | Qutenza |
| Sanofi-Aventis U.S. LLC | $21.99 | 2023 | |
| Amgen INC. | $17.41 | 2019 | |
| Brainscope Company, INC. | $17.40 | 2019 | |
| Depuy Synthes Sales INC. | $17.32 | 2022 | |
| Horizon Therapeutics Plc | $16.80 | 2023 | Krystexxa |
| Boston Scientific Corporation | $15.78 | 2024 | Spyglass Discover |
| Orexo US, INC. | $15.74 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Agee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.